Researchers Identified 60 Gene Changes in Bipolar Disorder
The study reveals potential molecular drivers of the condition, offering new targets for further research.
Updated on Sept. 28, 2026 in Life Sciences
Live Poll
Do you believe genetic research will lead to significantly better treatments for bipolar disorder?
Researchers identified 60 significant differentially expressed genes by sequencing mRNA from 31 lymphoblastoid cell lines collected from eight multiplex bipolar disorder families. This study marks a research-stage advance in understanding the genetic expression patterns associated with the condition.
Why it matters
Genetic risk variants in bipolar disorder may trigger substantial gene expression changes, potentially altering ion transmembrane transport. This study provides new targets for understanding the molecular foundation of the disorder.
The study identified 60 genes, with LINC01237 showing the highest significance at an adjusted p-value of 4.1E-07. Researchers categorized these into five bipolar-associated expression modules through Weighted Gene Co-expression Network Analysis.
The players
Nature
A multidisciplinary scientific journal that publishes peer-reviewed research across the life and physical sciences.
The details
Researchers performed RNA sequencing—a method used to measure the quantity and sequence of RNA in a sample—on total mRNA from lymphoblastoid cell lines, which are white blood cells treated to divide indefinitely. They utilized Weighted Gene Co-expression Network Analysis, a computational technique used to identify clusters of genes that show coordinated activity, to map gene expression to specific biological pathways. The findings link these expression changes to ion transmembrane transport and gated channel activities, which are critical for neuronal function.
Timeline
September 28, 2026: The research findings were published.
The Tech Race
This research builds upon existing GWAS statistics to validate its findings regarding gene expression modules. By utilizing brain-derived RNAseq data, it moves closer to defining the functional consequences of established bipolar disorder risk loci.
These findings are currently limited to laboratory research and do not represent a diagnostic tool or treatment for patients. The research establishes a set of prioritized genes that will require further study to determine their role in the pathology of bipolar disorder.
The takeaway
The study highlights how specific ion transport pathways might be dysregulated in bipolar disorder patients. Future research will need to determine if these expression changes can be observed in broader clinical cohorts beyond the lymphoblastoid cell lines used here.
Further reading
For more on the latest research in the field, visit the Life Sciences section.
More information
Read the complete peer-reviewed research article to explore the full methodology and gene expression data.
Source note: This article includes information reported by Nature.
Live Poll
Do you believe genetic research will lead to significantly better treatments for bipolar disorder?
